Yun Zhong, PhD is a Director and BTIG Biotechnology Analyst, specializing in gene therapy, genetic medicine, targeted therapy, rare disease and hematology. Prior to BTIG, Dr. Zhong was a Biotech Equity Research Analyst at Berenberg Capital Markets. Previously, he was Director within Biotech Equity Research at Janney Montgomery Scott. Earlier in his career, Dr. Zhong was a Vice President within Biotech Equity Research at SunTrust Robinson Humphrey, and a Biotech Equity Research Associate at Cowen. He earned a PhD in molecular biology and neuroscience from Rockefeller University, and an MS in biophysical engineering and BS in biophysical engineering from Osaka University.